Literature DB >> 16411062

The epidemiology of prolactinomas.

Antonio Ciccarelli1, Adrian F Daly, Albert Beckers.   

Abstract

Prolactin-secreting tumors (prolactinomas), the most frequently occurring pituitary tumor, have a frequency that varies with age and sex. They occur most frequently in females aged 20 to 50 years old, at which time the female-to-male ratio is approximately 10:1. In the pediatric-adolescent age group, prolactinomas have a prevalence of 100/million population, and account for less than 2% of all intracranial tumors. Prolactinomas occur in approximately 30% of patients with multiple endocrine neoplasia type 1 and in this setting, they may be more aggressive than their sporadic counterparts. Patients with Carney complex or McCune-Albright syndrome may exhibit hyperprolactinemia due to a pituitary tumor derived from somatomammotropic cells that secrete both growth hormone and prolactin. Few familial cases of prolactinoma unrelated to MEN-1 are reported in literature.

Entities:  

Mesh:

Year:  2005        PMID: 16411062     DOI: 10.1007/s11102-005-5079-0

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  32 in total

1.  The presentation and management of pituitary tumours in the elderly.

Authors:  D L Cohen; J S Bevan; C B Adams
Journal:  Age Ageing       Date:  1989-07       Impact factor: 10.668

Review 2.  Growth-hormone and prolactin excess.

Authors:  A Colao; G Lombardi
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

3.  Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study.

Authors:  E Delgrange; J Trouillas; D Maiter; J Donckier; J Tourniaire
Journal:  J Clin Endocrinol Metab       Date:  1997-07       Impact factor: 5.958

Review 4.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

5.  McCune-Albright syndrome: growth hormone dynamics in pregnancy.

Authors:  K Obuobie; V Mullik; C Jones; R John; A E Rees; J S Davies; M F Scanlon; J H Lazarus
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

6.  Pituitary adenomas in old age.

Authors:  K Kovacs; N Ryan; E Horvath; W Singer; C Ezrin
Journal:  J Gerontol       Date:  1980-01

7.  Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related diseases.

Authors:  J Poncin; R Abs; B Velkeniers; M Bonduelle; M Abramowicz; J J Legros; A Verloes; M Meurisse; L Van Gaal; C Verellen; L Koulischer; A Beckers
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

8.  Age-related and gender-related occurrence of pituitary adenomas.

Authors:  T Mindermann; C B Wilson
Journal:  Clin Endocrinol (Oxf)       Date:  1994-09       Impact factor: 3.478

Review 9.  Acromegaly with fibrous dysplasia: McCune-Albright Syndrome -- clinical studies in 3 cases and brief review of literature--.

Authors:  Anil Bhansali; Bhawani S Sharma; Polupoina Sreenivasulu; Paramjit Singh; Rakesh K Vashisth; Radharaman J Dash
Journal:  Endocr J       Date:  2003-12       Impact factor: 2.349

10.  Familial prolactinoma.

Authors:  M Berezin; A Karasik
Journal:  Clin Endocrinol (Oxf)       Date:  1995-05       Impact factor: 3.478

View more
  66 in total

1.  Effect of dopaminergic drug treatment on surgical findings in prolactinomas.

Authors:  Maria Menucci; Alfredo Quiñones-Hinojosa; Peter Burger; Roberto Salvatori
Journal:  Pituitary       Date:  2011-03       Impact factor: 4.107

Review 2.  Medical treatment of prolactinomas.

Authors:  Annamaria Colao; Silvia Savastano
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

3.  Retinal layers in prolactinoma patients: a spectral-domain optical coherence tomography study.

Authors:  Berna Evranos Ogmen; Nagihan Ugurlu; Sevgül Faki; Sefika Burcak Polat; Reyhan Ersoy; Bekir Cakir
Journal:  Int Ophthalmol       Date:  2021-01-22       Impact factor: 2.031

4.  Giant prolactinomas: clinical manifestations and outcomes of 16 Arab cases.

Authors:  Mussa H Almalki; Badurudeen Buhary; Saad Alzahrani; Fahad Alshahrani; Safia Alsherbeni; Ghada Alhowsawi; Naji Aljohani
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

5.  Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference.

Authors:  Julie Kreutz; Laurent Vroonen; Francoise Cattin; Patrick Petrossians; Albert Thiry; Liliya Rostomyan; Luaba Tshibanda; Albert Beckers; Jean-François Bonneville
Journal:  Neuroradiology       Date:  2015-04-07       Impact factor: 2.804

6.  Cabergoline for the treatment of bromocriptine-resistant invasive giant prolactinomas.

Authors:  Hai Yan Huang; Weiwei Zhai; Hao Tang; Guo Zhen Hui; Zhe Bao Wu
Journal:  Endocrine       Date:  2018-09-20       Impact factor: 3.633

7.  Pons herniation into skull base after cabergoline therapy of giant prolactinoma.

Authors:  Jesús Moles Herbera; David Rivero Celada; Inmaculada Montejo Gañan; David Fustero de Miguel; Carlos Fuentes Uliaque; Ana Carmen Vela Marín
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

8.  Cabergoline versus bromocriptine for the treatment of giant prolactinomas: A quantitative and systematic review.

Authors:  Hai Yan Huang; Shao Jian Lin; Wei Guo Zhao; Zhe Bao Wu
Journal:  Metab Brain Dis       Date:  2018-03-15       Impact factor: 3.584

9.  Dopamine agonist therapy induces significant recovery of HPA axis function in prolactinomas independent of tumor size: a large single center experience.

Authors:  Christine G Yedinak; Isabelle Cetas; Alp Ozpinar; Shirley McCartney; Aclan Dogan; Maria Fleseriu
Journal:  Endocrine       Date:  2016-07-26       Impact factor: 3.633

10.  Advances in the Diagnosis, Treatment, and Molecular Genetics of Pituitary Adenomas in Childhood.

Authors:  Margaret F Keil; Constantine A Stratakis
Journal:  US Endocrinol       Date:  2009-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.